Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Shockwave Medical Inc (NQ: SWAV )

214.24 +3.40 (+1.61%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 24, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Shockwave Medical Inc

< Previous 1 2 3 4 5 6 Next >
Benzinga's Top Ratings Upgrades, Downgrades For December 12, 2022
 
Via Benzinga
ShockWave Medical Earnings Perspective: Return On Capital Employed
 
Via Benzinga
ShockWave Medical (SWAV) Q3 2022 Earnings Call Transcript
SWAV earnings call for the period ending September 30, 2022. 
Via The Motley Fool
Nasdaq Bear Market: 3 Unstoppable Growth Stocks to Buy at Knocked-Down Prices
The road ahead of these businesses is a lot smoother than you'd think by looking at their stock prices. 
Via The Motley Fool
7 Index Funds to Buy to Retire a Millionaire
Although the market shows signs of improvement, the waters are still choppy enough for investors to focus on index funds to buy. 
Via InvestorPlace
3 Beaten-Down Growth Stocks That Billionaires Are Buying With Both Hands
Some of the world's most successful investors can't get enough of The Trade Desk, Shockwave Medical, and SoFi Technologies. 
Via The Motley Fool
Shockwave Medical to Participate in the Piper Sandler 34th Annual Healthcare Conference
From Shockwave Medical, Inc.
Via Globe NewsWire
$10,000 Invested in These Growth Stocks Could Make You a Fortune Over the Next 10 Years
Long-term investors should consider the high upside of these growth stocks. 
Via The Motley Fool
InMode Stock Shows Improved Technical Strength; Hits Key Technical Threshold
The Relative Strength (RS) Rating for InMode stock moved up into a higher percentile Wednesday, as it got a lift from 64 to 78. 
Via Investor's Business Daily
Shockwave Medical Publishes Inaugural ESG Report
From Shockwave Medical, Inc.
Via Globe NewsWire
This Stock Is Up 106% In 2022 And Analysts Love It, But Jim Cramer Says 'There's Too Much Political Risk'
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Rocket Pharmaceuticals Inc (NASDAQ: RCKT) is a "very early stage company that has a lot in the pipe. I tend to like these companies." 
Via Benzinga
2 Stocks I'd Buy Right Now Without Hesitation
One's a growth stock and the other pays a dividend but both of these healthcare businesses have what it takes to reliably outperform. 
Via The Motley Fool
Stock Market Rally Roars Higher On Cooling Inflation; Bitcoin, Meta, Tesla In Focus: Weekly Review
Bitcoin hit a two-year low while Meta and Tesla were in focus. 
Via Investor's Business Daily
Here's the Best Growth Stock to Buy Right Now If You're Worried About a Recession
Macroeconomic pressures aren't much of an issue when all your customers are cardiovascular surgeons. 
Via The Motley Fool
Perrigo, Tripadvisor, Lyft, And Some Other Big Stocks Moving Lower On Tuesday
U.S. stocks traded higher, with the Dow Jones gaining more than 400 points on Tuesday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
Where ShockWave Medical Stands With Analysts
Over the past 3 months, 4 analysts have published their opinion on ShockWave Medical (NASDAQ:SWAV) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding... 
Via Benzinga
Shockwave Medical Reports Third Quarter 2022 Financial Results
From Shockwave Medical, Inc.
Via Globe NewsWire
Earnings Preview: ShockWave Medical
ShockWave Medical (NASDAQ:SWAV) is set to give its latest quarterly earnings report on Monday, 2022-11-07. Here's what investors need to know before the announcement. Analysts estimate that ShockWave... 
Via Benzinga
Best and Worst Performing Stocks Since Rate Hikes Began
Looking at the S&P 1500, which includes large-caps, mid-caps, and small-caps, the average stock in the index is down 7.1% since the close on March 16th after the first rate hike. 
Via Talk Markets
Shockwave Confirms Consistent Outcomes for IVL in the Largest Prospective “Real World” Study of Patients with Heavily Calcified Peripheral Arterial Disease
Disrupt PAD III Observational Study Results Confirm Safety and Effectiveness of IVL in Patients with Complex Calcified Lesions 
From Shockwave Medical, Inc.
Via Globe NewsWire
Earnings Scheduled For November 7, 2022
Companies Reporting Before The Bell • NAPCO Security Techs (NASDAQ:NSSC) is expected to report quarterly earnings at $0.13 per share on revenue of $36.34 million. 
Via Benzinga
Ranking 7 Top Tech Stocks to Buy From Biggest to Smallest
Although "Big Tech" is currently struggling, but there are still many good top tech stocks to buy at this point. 
Via InvestorPlace
Nasdaq Bear Market: 3 Growth Stocks You'll Regret Not Buying at Knocked-Down Prices
Scooping up shares of these fast-growing businesses on the dip could do wonders for your portfolio over time. 
Via The Motley Fool
Opportunities In Large Cap Growth And Small Cap
The third quarter was true 
Via Talk Markets
Shockwave Medical Announces Details for Conference Call Discussing Third Quarter 2022 Results
From Shockwave Medical, Inc.
Via Globe NewsWire
7 Little-Known Stocks With Millionaire-Maker Potential
The unprecedented number of tech revolutions has made it easier than ever to identify many potential millionaire-maker stocks to buy. 
Via InvestorPlace
Eli Lilly Leads 5 Stocks To Watch In Bear Market
Eli Lilly is holding up, while others crumbled Friday amid the market sell-off. 
Via Investor's Business Daily
2 Medical Device Makers Crushing the Market
One company is an industry disruptor with big upside potential, while the other is a huge, diversified company. 
Via The Motley Fool
Leading Medical Stocks, Including Sensus And Shockwave, Have Grown At Least 36% This Year
Biotech isn't the only place to make money in health care this year. 
Via Investor's Business Daily
Cutera Stock Earns Relative Strength Rating Upgrade
On Monday, medical aesthetic Cutera stock had its Relative Strength (RS) Rating upgraded to 90 from 80 a day earlier. 
Via Investor's Business Daily
< Previous 1 2 3 4 5 6 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.